As Target-to-Lead (T2L) experts, Icagen scientists were born from biotech and later pharma matured. Icagen’s scientific teams are a defining feature of the company, with industry-leading expertise and a proven track record of drug discovery from target identification through clinical evaluation for multiple classes of targets. Icagen’s mission is to harness the scientific expertise of our teams to provide the capability and know-how to advance our clients’ early drug discovery programs.
Our knowledge base crosses multiple disciplines including molecular biology, cell biology (including stem cell biology), biochemistry, electrophysiology, high throughput screening, and chemistry. We direct this experience to produce high-quality data for our clients and collaborators leading to the development and progression of the most promising candidates even for challenging targets.